Skip to main content
Top
Published in: BMC Public Health 1/2006

Open Access 01-12-2006 | Research article

Avoidable mortality across Canada from 1975 to 1999

Authors: Paul D James, Doug G Manuel, Yang Mao

Published in: BMC Public Health | Issue 1/2006

Login to get access

Abstract

Background

The concept of 'avoidable' mortality (AM) has been proposed as a performance measure of health care systems. In this study we examined mortality in five geographic regions of Canada from 1975 to 1999 for previously defined avoidable disease groups that are amenable to medical care and public health. These trends were compared to mortality from other causes.

Methods

National and regional age-standardized mortality rates for ages less than 65 years were estimated for avoidable and other causes of death for consecutive periods (1975–1979, 1980–1985, 1985–1989, 1990–1994, and 1995–1999). The proportion of all-cause mortality attributable to avoidable causes was also determined.

Results

From 1975–1979 to 1995–1999, the AM decrease (46.9%) was more pronounced compared to mortality from other causes (24.9%). There were persistent regional AM differences, with consistently lower AM in Ontario and British Columbia compared to the Atlantic, Quebec, and Prairies regions. This trend was not apparent when mortality from other causes was examined. Injuries, ischaemic heart disease, and lung cancer strongly influenced the overall AM trends.

Conclusion

The regional differences in mortality for ages less than 65 years was attributable to causes of death amenable to medical care and public health, especially from causes responsive to public health.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rutstein DD, Berenberg W, Chalmers TC, Child CGD, Fishman AP, Perrin EB: Measuring the quality of medical care. A clinical method. N Engl J Med. 1976, 294: 582-8.CrossRefPubMed Rutstein DD, Berenberg W, Chalmers TC, Child CGD, Fishman AP, Perrin EB: Measuring the quality of medical care. A clinical method. N Engl J Med. 1976, 294: 582-8.CrossRefPubMed
2.
go back to reference Charlton JR, Velez R: Some international comparisons of mortality amenable to medical intervention. Br Med J. 1986, 292: 295-301.CrossRef Charlton JR, Velez R: Some international comparisons of mortality amenable to medical intervention. Br Med J. 1986, 292: 295-301.CrossRef
3.
go back to reference Poikolainen K, Eskola J: The effect of health services on mortality: decline in death rates from amenable and non-amenable causes in Finland, 1969-81. Lancet. 1986, 1: 199-202. 10.1016/S0140-6736(86)90664-1.CrossRefPubMed Poikolainen K, Eskola J: The effect of health services on mortality: decline in death rates from amenable and non-amenable causes in Finland, 1969-81. Lancet. 1986, 1: 199-202. 10.1016/S0140-6736(86)90664-1.CrossRefPubMed
4.
go back to reference Westerling R: Trends in "avoidable" mortality in Sweden, 1974-1985. JECH. 1992, 46: 489-93. Westerling R: Trends in "avoidable" mortality in Sweden, 1974-1985. JECH. 1992, 46: 489-93.
5.
go back to reference Desmeules M, Semenciw R: The impact of medical care on mortality in Canada, 1959-1988. Can J Public Health. 1991, 82: 209-11.PubMed Desmeules M, Semenciw R: The impact of medical care on mortality in Canada, 1959-1988. Can J Public Health. 1991, 82: 209-11.PubMed
6.
go back to reference Mackenbach JP, Looman CW, Kunst AE, Habbema JD, van der Maas PJ: Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands. Soc Sci Med. 1988, 27: 889-894. 10.1016/0277-9536(88)90278-X.CrossRefPubMed Mackenbach JP, Looman CW, Kunst AE, Habbema JD, van der Maas PJ: Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands. Soc Sci Med. 1988, 27: 889-894. 10.1016/0277-9536(88)90278-X.CrossRefPubMed
7.
go back to reference Mackenbach JP, Kunst AE, Looman CW, Habbema JD, van der Maas PJ: Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods. JECH. 1988, 42: 325-32. Mackenbach JP, Kunst AE, Looman CW, Habbema JD, van der Maas PJ: Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods. JECH. 1988, 42: 325-32.
8.
go back to reference Kunst AE, Looman CW, Mackenbach JP: Medical care and regional mortality differences within the countries of the European community. Eur J Popul. 1988, 4: 223-245. 10.1007/BF01796895.CrossRefPubMed Kunst AE, Looman CW, Mackenbach JP: Medical care and regional mortality differences within the countries of the European community. Eur J Popul. 1988, 4: 223-245. 10.1007/BF01796895.CrossRefPubMed
9.
go back to reference Humblet PC, Lagasse R, Leveque A: Trends in Belgian premature avoidable deaths over a 20 year period. J Epidemiol Community Health. 2000, 54: 687-691. 10.1136/jech.54.9.687.CrossRefPubMedPubMedCentral Humblet PC, Lagasse R, Leveque A: Trends in Belgian premature avoidable deaths over a 20 year period. J Epidemiol Community Health. 2000, 54: 687-691. 10.1136/jech.54.9.687.CrossRefPubMedPubMedCentral
10.
go back to reference Westerling R, Smedby B: The European Community 'avoidable death indicators' in Sweden 1974-1985. Int J Epidemiol. 1992, 21: 502-10.CrossRefPubMed Westerling R, Smedby B: The European Community 'avoidable death indicators' in Sweden 1974-1985. Int J Epidemiol. 1992, 21: 502-10.CrossRefPubMed
11.
12.
go back to reference Manuel DG, Goel V: 2002, Toronto, Ontario Hospital Association, Population Health Indicators for Measuring Health System Performance Hospital Report 2001 Manuel DG, Goel V: 2002, Toronto, Ontario Hospital Association, Population Health Indicators for Measuring Health System Performance Hospital Report 2001
14.
go back to reference Nolte E, Scholz R, Shkolnikov V, McKee M: The contribution of medical care to changing life expectancy in Germany and Poland. Soc Sci Med. 2002, 55: 1905-1921. 10.1016/S0277-9536(01)00320-3.CrossRefPubMed Nolte E, Scholz R, Shkolnikov V, McKee M: The contribution of medical care to changing life expectancy in Germany and Poland. Soc Sci Med. 2002, 55: 1905-1921. 10.1016/S0277-9536(01)00320-3.CrossRefPubMed
15.
go back to reference Charlton JR, Hartley RM, Silver R, Holland WW: Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet. 1983, 1: 691-6. 10.1016/S0140-6736(83)91981-5.CrossRefPubMed Charlton JR, Hartley RM, Silver R, Holland WW: Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet. 1983, 1: 691-6. 10.1016/S0140-6736(83)91981-5.CrossRefPubMed
16.
go back to reference Holland WW, EC Working Group on Health Services and 'Avoidable Death': European Community Atlas of 'Avoidable Death'. 1997, Oxford, Oxford University Press Holland WW, EC Working Group on Health Services and 'Avoidable Death': European Community Atlas of 'Avoidable Death'. 1997, Oxford, Oxford University Press
17.
go back to reference Brownell M, Friesen D, Mayer T: Childhood injury rates in Manitoba: socioeconomic influences. Can J Public Health. 2002, 93 Suppl 2:S50-6: S50-S56. Brownell M, Friesen D, Mayer T: Childhood injury rates in Manitoba: socioeconomic influences. Can J Public Health. 2002, 93 Suppl 2:S50-6: S50-S56.
18.
go back to reference Mo F, Choi BCK, Clottey C, LeBrun B, Robbins G: Characteristics and risk factors for accident injury in Canada form 1986 to 1996: An analysis of the Canadian Accident Injury Reporting and Evaluation (CAIRE) database. Injury Control and Safety Promotion. 2002, 9: 73-81. 10.1076/icsp.9.2.73.8701.CrossRefPubMed Mo F, Choi BCK, Clottey C, LeBrun B, Robbins G: Characteristics and risk factors for accident injury in Canada form 1986 to 1996: An analysis of the Canadian Accident Injury Reporting and Evaluation (CAIRE) database. Injury Control and Safety Promotion. 2002, 9: 73-81. 10.1076/icsp.9.2.73.8701.CrossRefPubMed
19.
go back to reference Cusimano MD, Mukhida K: Acute injuries research in Canada. 2003, Canadian Institute for Health Research, 1-23. Cusimano MD, Mukhida K: Acute injuries research in Canada. 2003, Canadian Institute for Health Research, 1-23.
20.
go back to reference Macpherson AK, To TM, Macarthur C, Chipman ML, Wright JG, Parkin PC: Impact of mandatory helmet legislation on bicycle-related head injuries in children: A population-based study. Pediatrics. 2005, 110: 60-65. 10.1542/peds.110.5.e60.CrossRef Macpherson AK, To TM, Macarthur C, Chipman ML, Wright JG, Parkin PC: Impact of mandatory helmet legislation on bicycle-related head injuries in children: A population-based study. Pediatrics. 2005, 110: 60-65. 10.1542/peds.110.5.e60.CrossRef
21.
go back to reference Filate WA, Johansen HL, Kennedy CC, Tu JV: Regional variations in cardiovascular mortality in Canada. Can J Cardiol. 2003, 19: 1241-1248.PubMed Filate WA, Johansen HL, Kennedy CC, Tu JV: Regional variations in cardiovascular mortality in Canada. Can J Cardiol. 2003, 19: 1241-1248.PubMed
22.
go back to reference Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H: Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 1249-1259.PubMed Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H: Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 1249-1259.PubMed
23.
go back to reference Manuel DG, Leung M, Nguyen K, Tanuseputro P: Burden of cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 997-1004.PubMed Manuel DG, Leung M, Nguyen K, Tanuseputro P: Burden of cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 997-1004.PubMed
24.
go back to reference Illing EMM, Kaiserman MJ: Mortality attributable to tobacco use in Canada and its regions, 1994 and 1996. Chronic Dis Can. 1999, 20: 111-117. Illing EMM, Kaiserman MJ: Mortality attributable to tobacco use in Canada and its regions, 1994 and 1996. Chronic Dis Can. 1999, 20: 111-117.
25.
go back to reference Wilkins R, Berthelot JM, Ng E: Trends in Mortality by Neighbourhood Income in Urban Canada from 1971 to 1996. Health Rep. 2002, 13: 45-71. Wilkins R, Berthelot JM, Ng E: Trends in Mortality by Neighbourhood Income in Urban Canada from 1971 to 1996. Health Rep. 2002, 13: 45-71.
26.
go back to reference Wigle DT, Mao Y, Semenciw R, McCann C, Davies JW: Premature deaths in Canada: impact, trends and opportunities for prevention [published erratum appears in Can J Public Health 1991 Jan-Feb;82(1):26]. Canadian Journal of Public Health-Revue Canadienne De Sante Publique. 1990, 81: 376-81.PubMed Wigle DT, Mao Y, Semenciw R, McCann C, Davies JW: Premature deaths in Canada: impact, trends and opportunities for prevention [published erratum appears in Can J Public Health 1991 Jan-Feb;82(1):26]. Canadian Journal of Public Health-Revue Canadienne De Sante Publique. 1990, 81: 376-81.PubMed
27.
go back to reference Holland WW, Fitzgerald AP, Hildrey SJ, Phillips SJ: Heaven can wait. J Public Health Med. 1994, 16: 321-30.PubMed Holland WW, Fitzgerald AP, Hildrey SJ, Phillips SJ: Heaven can wait. J Public Health Med. 1994, 16: 321-30.PubMed
28.
go back to reference Charlton JR, Bauer R, Lakhani A: Outcome measures for district and regional health care planners. Community Med. 1984, 6: 306-15.PubMed Charlton JR, Bauer R, Lakhani A: Outcome measures for district and regional health care planners. Community Med. 1984, 6: 306-15.PubMed
29.
go back to reference Holland W: Avoidable death as a measure of quality. Quality Assurance in Health Care. 1990, 2: 227-33.CrossRefPubMed Holland W: Avoidable death as a measure of quality. Quality Assurance in Health Care. 1990, 2: 227-33.CrossRefPubMed
30.
go back to reference Mackenbach JP, Bouvier-Colle MH, Jougla E: Avoidable mortality and health services: a review of aggregate data studies. JECH. 1990, 44: 106-11. Mackenbach JP, Bouvier-Colle MH, Jougla E: Avoidable mortality and health services: a review of aggregate data studies. JECH. 1990, 44: 106-11.
31.
go back to reference French KM, Jones K: Impact of definition on the study of avoidable mortality: geographical trends in British deaths 1981-1998 using Charlton and Holland's definitions. Soc Sci Med. 2006, 62: 1443-1456. 10.1016/j.socscimed.2005.08.002.CrossRefPubMed French KM, Jones K: Impact of definition on the study of avoidable mortality: geographical trends in British deaths 1981-1998 using Charlton and Holland's definitions. Soc Sci Med. 2006, 62: 1443-1456. 10.1016/j.socscimed.2005.08.002.CrossRefPubMed
32.
go back to reference Carr-Hill RA, Hardman GF, Russell IT: Variations in avoidable mortality and variations in health care resources. Lancet. 1987, 1: 789-92. 10.1016/S0140-6736(87)92810-8.CrossRefPubMed Carr-Hill RA, Hardman GF, Russell IT: Variations in avoidable mortality and variations in health care resources. Lancet. 1987, 1: 789-92. 10.1016/S0140-6736(87)92810-8.CrossRefPubMed
33.
go back to reference Treurniet HF, Looman CWN, van der Maas PH, Mackenbach JP: Variations in "avoidable" mortality: a reflection of variations in incidence?. Int J Epidemiol. 1999, 28: 225-232. 10.1093/ije/28.2.225.CrossRefPubMed Treurniet HF, Looman CWN, van der Maas PH, Mackenbach JP: Variations in "avoidable" mortality: a reflection of variations in incidence?. Int J Epidemiol. 1999, 28: 225-232. 10.1093/ije/28.2.225.CrossRefPubMed
34.
go back to reference Mackenbach JP, Bouvier-Colle MH, Jougla E: "Avoidable" mortality and health services: a review of aggregate data studies. J Epidemiol Community Health. 1990, 44: 106-111.CrossRefPubMedPubMedCentral Mackenbach JP, Bouvier-Colle MH, Jougla E: "Avoidable" mortality and health services: a review of aggregate data studies. J Epidemiol Community Health. 1990, 44: 106-111.CrossRefPubMedPubMedCentral
35.
go back to reference Tobias M, Jackson G: Avoidable mortality in New Zealand, 1981-97. Aust N Z J Public Health. 2001, 25: 12-20.CrossRefPubMed Tobias M, Jackson G: Avoidable mortality in New Zealand, 1981-97. Aust N Z J Public Health. 2001, 25: 12-20.CrossRefPubMed
36.
go back to reference Linke A, Erbs S, Hambrecht R: Exercise and the coronary circulation-alterations and adaptations in coronary artery disease. Prog Cardiovasc Dis. 2006, 48: 270-284. 10.1016/j.pcad.2005.10.001.CrossRefPubMed Linke A, Erbs S, Hambrecht R: Exercise and the coronary circulation-alterations and adaptations in coronary artery disease. Prog Cardiovasc Dis. 2006, 48: 270-284. 10.1016/j.pcad.2005.10.001.CrossRefPubMed
37.
go back to reference Reiffel JA: Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clin Cardiol. 2005, 28: I28-I37.CrossRefPubMed Reiffel JA: Practical algorithms for pharmacologic management of the post myocardial infarction patient. Clin Cardiol. 2005, 28: I28-I37.CrossRefPubMed
38.
go back to reference Faxon DP: Coronary interventions and their impact on post myocardial infarction survival. Clin Cardiol. 2005, 28: I38-I44.CrossRefPubMed Faxon DP: Coronary interventions and their impact on post myocardial infarction survival. Clin Cardiol. 2005, 28: I38-I44.CrossRefPubMed
39.
go back to reference Courville KA, Lavie CJ, Milani RV: Lipid-lowering therapy for elderly patients at risk for coronary events and stroke. Am Heart Hosp J. 2005, 3: 256-262.CrossRefPubMed Courville KA, Lavie CJ, Milani RV: Lipid-lowering therapy for elderly patients at risk for coronary events and stroke. Am Heart Hosp J. 2005, 3: 256-262.CrossRefPubMed
40.
go back to reference Boodhwani M, Rubens FD, Sellke FW, Mesana TG, Ruel M: Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-analysis. Eur J Cardiothorac Surg. 2006, 29: 65-70. 10.1016/j.ejcts.2005.07.020.CrossRefPubMed Boodhwani M, Rubens FD, Sellke FW, Mesana TG, Ruel M: Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-analysis. Eur J Cardiothorac Surg. 2006, 29: 65-70. 10.1016/j.ejcts.2005.07.020.CrossRefPubMed
41.
go back to reference Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E: One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005, 130: 512-519. 10.1016/j.jtcvs.2004.12.049.CrossRefPubMed Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E: One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005, 130: 512-519. 10.1016/j.jtcvs.2004.12.049.CrossRefPubMed
42.
go back to reference Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC: Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005, 293: 2767-2775. 10.1001/jama.293.22.2767.CrossRefPubMed Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC: Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005, 293: 2767-2775. 10.1001/jama.293.22.2767.CrossRefPubMed
43.
go back to reference Lalloo UG, Naidoo R, Ambaram A: Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis. Curr Opin Pulm Med. 2006, 12: 179-185. 10.1097/01.mcp.0000219266.27439.52.CrossRefPubMed Lalloo UG, Naidoo R, Ambaram A: Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis. Curr Opin Pulm Med. 2006, 12: 179-185. 10.1097/01.mcp.0000219266.27439.52.CrossRefPubMed
44.
go back to reference Jatoi I, Miller AB: Why is breast-cancer mortality declining?. Lancet Oncol. 2003, 4: 251-254. 10.1016/S1470-2045(03)01037-4.CrossRefPubMed Jatoi I, Miller AB: Why is breast-cancer mortality declining?. Lancet Oncol. 2003, 4: 251-254. 10.1016/S1470-2045(03)01037-4.CrossRefPubMed
45.
go back to reference Ringash J: Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ. 2001, 164: 469-476.PubMedPubMedCentral Ringash J: Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ. 2001, 164: 469-476.PubMedPubMedCentral
46.
go back to reference Dang CT: Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions. Expert Rev Anticancer Ther. 2006, 6: 427-436. 10.1586/14737140.6.3.427.CrossRefPubMed Dang CT: Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions. Expert Rev Anticancer Ther. 2006, 6: 427-436. 10.1586/14737140.6.3.427.CrossRefPubMed
47.
go back to reference Witherby SM, Muss HB: Update in medical oncology for older patients: focus on breast cancer: management of early breast cancer. Cancer J. 2005, 11: 506-517.CrossRefPubMed Witherby SM, Muss HB: Update in medical oncology for older patients: focus on breast cancer: management of early breast cancer. Cancer J. 2005, 11: 506-517.CrossRefPubMed
48.
go back to reference Sigurdsson K, Sigvaldason H: Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand. 2006, 85: 343-349.CrossRefPubMed Sigurdsson K, Sigvaldason H: Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand. 2006, 85: 343-349.CrossRefPubMed
49.
go back to reference Taylor R, Morrell S, Mamoon H, Wain G, Ross J: Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (australia). Cancer Causes Control. 2006, 17: 299-306. 10.1007/s10552-005-0515-z.CrossRefPubMed Taylor R, Morrell S, Mamoon H, Wain G, Ross J: Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (australia). Cancer Causes Control. 2006, 17: 299-306. 10.1007/s10552-005-0515-z.CrossRefPubMed
50.
go back to reference Carey MS, Gawlik C, Fung-Kee-Fung M, Chambers A, Oliver T: Systematic review of systemic therapy for advanced or recurrent endometrial cancer. Gynecol Oncol. 2006, 101: 158-167. 10.1016/j.ygyno.2005.11.019.CrossRefPubMed Carey MS, Gawlik C, Fung-Kee-Fung M, Chambers A, Oliver T: Systematic review of systemic therapy for advanced or recurrent endometrial cancer. Gynecol Oncol. 2006, 101: 158-167. 10.1016/j.ygyno.2005.11.019.CrossRefPubMed
51.
go back to reference Humber C, Tierney J, Symonds P, Collingwood M, Kirwan J, Williams C, Green J: Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database Syst Rev. 2005, CD003915- Humber C, Tierney J, Symonds P, Collingwood M, Kirwan J, Williams C, Green J: Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database Syst Rev. 2005, CD003915-
52.
go back to reference Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, Zee B: Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group. J Clin Oncol. 1997, 15: 1638-1645.PubMed Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, O'Reilly SE, Pater J, Quirt I, Sadura A, Shustik C, Skillings J, Sutcliffe S, Verma S, Yoshida S, Zee B: Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group. J Clin Oncol. 1997, 15: 1638-1645.PubMed
53.
go back to reference Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Bezjak A, Wells WA, Burns BF, Winter JN, Horning SJ, Dar AR, Djurfeldt MS, Ding K, Shepherd LE: Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol. 2005, 23: 4634-4642. 10.1200/JCO.2005.09.085.CrossRefPubMed Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Bezjak A, Wells WA, Burns BF, Winter JN, Horning SJ, Dar AR, Djurfeldt MS, Ding K, Shepherd LE: Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol. 2005, 23: 4634-4642. 10.1200/JCO.2005.09.085.CrossRefPubMed
54.
go back to reference Gospodarowicz MK, Sutcliffe SB, Clark RM, Dembo AJ, Fitzpatrick PJ, Munro AJ, Bergsagel DE, Patterson BJ, Tsang R, Chua T, .: Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys. 1992, 22: 859-865.CrossRefPubMed Gospodarowicz MK, Sutcliffe SB, Clark RM, Dembo AJ, Fitzpatrick PJ, Munro AJ, Bergsagel DE, Patterson BJ, Tsang R, Chua T, .: Analysis of supradiaphragmatic clinical stage I and II Hodgkin's disease treated with radiation alone. Int J Radiat Oncol Biol Phys. 1992, 22: 859-865.CrossRefPubMed
55.
go back to reference Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J: Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005, 65: 794-801.CrossRefPubMed Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J: Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005, 65: 794-801.CrossRefPubMed
56.
go back to reference Briel M, Studer M, Glass TR, Bucher HC: Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2004, 117: 596-606. 10.1016/j.amjmed.2004.04.022.CrossRefPubMed Briel M, Studer M, Glass TR, Bucher HC: Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2004, 117: 596-606. 10.1016/j.amjmed.2004.04.022.CrossRefPubMed
57.
go back to reference Wardlaw JM, Warlow CP, Counsell C: Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet. 1997, 350: 607-614. 10.1016/S0140-6736(97)03022-5.CrossRefPubMed Wardlaw JM, Warlow CP, Counsell C: Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet. 1997, 350: 607-614. 10.1016/S0140-6736(97)03022-5.CrossRefPubMed
58.
go back to reference Sidebotham HJ, Roche WR: Asthma deaths; persistent and preventable mortality. Histopathology. 2003, 43: 105-117. 10.1046/j.1365-2559.2003.01664.x.CrossRefPubMed Sidebotham HJ, Roche WR: Asthma deaths; persistent and preventable mortality. Histopathology. 2003, 43: 105-117. 10.1046/j.1365-2559.2003.01664.x.CrossRefPubMed
59.
go back to reference Suissa S, Ernst P: Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001, 107: 937-944. 10.1067/mai.2001.115653.CrossRefPubMed Suissa S, Ernst P: Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001, 107: 937-944. 10.1067/mai.2001.115653.CrossRefPubMed
60.
go back to reference Leontiadis GI, Sharma VK, Howden CW: Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2006, CD002094- Leontiadis GI, Sharma VK, Howden CW: Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2006, CD002094-
61.
go back to reference Lunevicius R, Morkevicius M: Systematic review comparing laparoscopic and open repair for perforated peptic ulcer. Br J Surg. 2005, 92: 1195-1207. 10.1002/bjs.5155.CrossRefPubMed Lunevicius R, Morkevicius M: Systematic review comparing laparoscopic and open repair for perforated peptic ulcer. Br J Surg. 2005, 92: 1195-1207. 10.1002/bjs.5155.CrossRefPubMed
62.
go back to reference Katkhouda N, Mason RJ, Towfigh S, Gevorgyan A, Essani R: Laparoscopic versus open appendectomy: a prospective randomized double-blind study. Ann Surg. 2005, 242: 439-448.PubMedPubMedCentral Katkhouda N, Mason RJ, Towfigh S, Gevorgyan A, Essani R: Laparoscopic versus open appendectomy: a prospective randomized double-blind study. Ann Surg. 2005, 242: 439-448.PubMedPubMedCentral
63.
go back to reference Cox MR, McCall JL, Toouli J, Padbury RT, Wilson TG, Wattchow DA, Langcake M: Prospective randomized comparison of open versus laparoscopic appendectomy in men. World J Surg. 1996, 20: 263-266. 10.1007/s002689900041.CrossRefPubMed Cox MR, McCall JL, Toouli J, Padbury RT, Wilson TG, Wattchow DA, Langcake M: Prospective randomized comparison of open versus laparoscopic appendectomy in men. World J Surg. 1996, 20: 263-266. 10.1007/s002689900041.CrossRefPubMed
64.
go back to reference Arregui ME, Young SB: Groin hernia repair by laparoscopic techniques: current status and controversies. World J Surg. 2005, 29: 1052-1057. 10.1007/s00268-005-7968-9.CrossRefPubMed Arregui ME, Young SB: Groin hernia repair by laparoscopic techniques: current status and controversies. World J Surg. 2005, 29: 1052-1057. 10.1007/s00268-005-7968-9.CrossRefPubMed
65.
go back to reference Bittner R: The standard of laparoscopic cholecystectomy. Langenbecks Arch Surg. 2004, 389: 157-163. 10.1007/s00423-004-0471-1.CrossRefPubMed Bittner R: The standard of laparoscopic cholecystectomy. Langenbecks Arch Surg. 2004, 389: 157-163. 10.1007/s00423-004-0471-1.CrossRefPubMed
66.
go back to reference Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF: WHO analysis of causes of maternal death: a systematic review. Lancet. 2006, 367: 1066-1074. 10.1016/S0140-6736(06)68397-9.CrossRefPubMed Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF: WHO analysis of causes of maternal death: a systematic review. Lancet. 2006, 367: 1066-1074. 10.1016/S0140-6736(06)68397-9.CrossRefPubMed
67.
go back to reference Bullough C, Meda N, Makowiecka K, Ronsmans C, Achadi EL, Hussein J: Current strategies for the reduction of maternal mortality. BJOG. 2005, 112: 1180-1188.CrossRefPubMed Bullough C, Meda N, Makowiecka K, Ronsmans C, Achadi EL, Hussein J: Current strategies for the reduction of maternal mortality. BJOG. 2005, 112: 1180-1188.CrossRefPubMed
68.
go back to reference Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L: Evidence-based, cost-effective interventions: how many newborn babies can we save?. Lancet. 2005, 365: 977-988. 10.1016/S0140-6736(05)71088-6.CrossRefPubMed Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L: Evidence-based, cost-effective interventions: how many newborn babies can we save?. Lancet. 2005, 365: 977-988. 10.1016/S0140-6736(05)71088-6.CrossRefPubMed
69.
go back to reference Dragnev KH, Stover D, Dmitrovsky E: Lung cancer prevention: the guidelines. Chest. 2003, 123: 60S-71S. 10.1378/chest.123.1_suppl.60S.CrossRefPubMed Dragnev KH, Stover D, Dmitrovsky E: Lung cancer prevention: the guidelines. Chest. 2003, 123: 60S-71S. 10.1378/chest.123.1_suppl.60S.CrossRefPubMed
70.
go back to reference Kelley MJ, McCrory DC: Prevention of lung cancer: summary of published evidence. Chest. 2003, 123: 50S-59S. 10.1378/chest.123.1_suppl.50S.CrossRefPubMed Kelley MJ, McCrory DC: Prevention of lung cancer: summary of published evidence. Chest. 2003, 123: 50S-59S. 10.1378/chest.123.1_suppl.50S.CrossRefPubMed
71.
go back to reference Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, Hoover R, Blair A: Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control. 2005, 16: 389-397. 10.1007/s10552-004-5026-9.CrossRefPubMedPubMedCentral Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, Hoover R, Blair A: Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control. 2005, 16: 389-397. 10.1007/s10552-004-5026-9.CrossRefPubMedPubMedCentral
72.
go back to reference Liu B, Ivers R, Norton R, Blows S, Lo SK: Helmets for preventing injury in motorcycle riders. Cochrane Database Syst Rev. 2004, CD004333- Liu B, Ivers R, Norton R, Blows S, Lo SK: Helmets for preventing injury in motorcycle riders. Cochrane Database Syst Rev. 2004, CD004333-
73.
go back to reference Philippakis A, Hemenway D, Alexe DM, Dessypris N, Spyridopoulos T, Petridou E: A quantification of preventable unintentional childhood injury mortality in the United States. Inj Prev. 2004, 10: 79-82. 10.1136/ip.2003.004119.CrossRefPubMedPubMedCentral Philippakis A, Hemenway D, Alexe DM, Dessypris N, Spyridopoulos T, Petridou E: A quantification of preventable unintentional childhood injury mortality in the United States. Inj Prev. 2004, 10: 79-82. 10.1136/ip.2003.004119.CrossRefPubMedPubMedCentral
74.
go back to reference Bunn F, Collier T, Frost C, Ker K, Roberts I, Wentz R: Traffic calming for the prevention of road traffic injuries: systematic review and meta-analysis. Inj Prev. 2003, 9: 200-204. 10.1136/ip.9.3.200.CrossRefPubMedPubMedCentral Bunn F, Collier T, Frost C, Ker K, Roberts I, Wentz R: Traffic calming for the prevention of road traffic injuries: systematic review and meta-analysis. Inj Prev. 2003, 9: 200-204. 10.1136/ip.9.3.200.CrossRefPubMedPubMedCentral
75.
go back to reference Attewell RG, Glase K, McFadden M: Bicycle helmet efficacy: a meta-analysis. Accid Anal Prev. 2001, 33: 345-352. 10.1016/S0001-4575(00)00048-8.CrossRefPubMed Attewell RG, Glase K, McFadden M: Bicycle helmet efficacy: a meta-analysis. Accid Anal Prev. 2001, 33: 345-352. 10.1016/S0001-4575(00)00048-8.CrossRefPubMed
76.
go back to reference Rivara FP, Thompson DC: Systematic reviews of injury-prevention strategies for occupational injuries: an overview. Am J Prev Med. 2000, 18: 1-3. 10.1016/S0749-3797(00)00134-3.CrossRefPubMed Rivara FP, Thompson DC: Systematic reviews of injury-prevention strategies for occupational injuries: an overview. Am J Prev Med. 2000, 18: 1-3. 10.1016/S0749-3797(00)00134-3.CrossRefPubMed
77.
go back to reference Rivara FP, Thompson DC, Cummings P: Effectiveness of primary and secondary enforced seat belt laws. Am J Prev Med. 1999, 16: 30-39. 10.1016/S0749-3797(98)00113-5.CrossRefPubMed Rivara FP, Thompson DC, Cummings P: Effectiveness of primary and secondary enforced seat belt laws. Am J Prev Med. 1999, 16: 30-39. 10.1016/S0749-3797(98)00113-5.CrossRefPubMed
Metadata
Title
Avoidable mortality across Canada from 1975 to 1999
Authors
Paul D James
Doug G Manuel
Yang Mao
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2006
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-6-137

Other articles of this Issue 1/2006

BMC Public Health 1/2006 Go to the issue